Glycolax



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Constipation 54.2%
Drug Use For Unknown Indication 25.0%
Colonoscopy 8.3%
Abdominal Pain 4.2%
Intestinal Obstruction 4.2%
Irritable Bowel Syndrome 4.2%
Gastrointestinal Hypomotility 9.5%
Pharmaceutical Product Complaint 9.5%
Talipes 9.5%
Therapeutic Response Unexpected With Drug Substitution 9.5%
Diabetes Mellitus 4.8%
Gastrointestinal Obstruction 4.8%
Intestinal Obstruction 4.8%
Malaise 4.8%
Obsessive-compulsive Disorder 4.8%
Parosmia 4.8%
Rash Pruritic 4.8%
Reaction To Drug Excipients 4.8%
Speech Disorder Developmental 4.8%
Swelling Face 4.8%
Treatment Noncompliance 4.8%
Vomiting 4.8%
Wound Haemorrhage 4.8%
Secondary
Drug Use For Unknown Indication 42.1%
Constipation 36.8%
Hypothyroidism 10.5%
Breast Cancer Metastatic 5.3%
Ileus Paralytic 5.3%
Talipes 50.0%
Alopecia 8.3%
Intestinal Obstruction 8.3%
Mania 8.3%
Pharyngeal Oedema 8.3%
Pregnancy 8.3%
Rash 8.3%
Concomitant
Product Used For Unknown Indication 25.9%
Drug Use For Unknown Indication 10.6%
Pain 9.3%
Constipation 8.7%
Hypertension 5.8%
Depression 4.7%
Gastrooesophageal Reflux Disease 4.3%
Osteoporosis 4.3%
Chronic Obstructive Pulmonary Disease 3.1%
Back Pain 2.9%
Multiple Myeloma 2.9%
Anxiety 2.7%
Fatigue 2.3%
Multiple Sclerosis 2.1%
Panic Attack 2.0%
Breast Cancer 1.7%
Hypercalcaemia 1.7%
Breast Cancer Metastatic 1.6%
Nausea 1.6%
Sleep Disorder 1.6%
Weight Decreased 12.4%
Weight Increased 10.4%
Vomiting 9.1%
Wheezing 7.9%
Urinary Tract Infection 7.1%
White Blood Cell Count Decreased 6.6%
Wound Infection Staphylococcal 5.8%
Wound Drainage 4.6%
Wrist Fracture 4.6%
Pneumonia 3.7%
White Blood Cell Count Increased 3.7%
Pain In Extremity 3.3%
Sleep Apnoea Syndrome 3.3%
Unresponsive To Stimuli 2.9%
Ventricular Fibrillation 2.9%
Intestinal Perforation 2.5%
Therapeutic Agent Toxicity 2.5%
Type 2 Diabetes Mellitus 2.5%
Pain 2.1%
Syncope 2.1%